Article
Successful treatment of Trichosporon mucoides infection with lipid complex amphotericin B and 5-fluorocytosine.
Mycoses (impact factor:
2.25).
06/2006;
49(3):251-3.
DOI:10.1111/j.1439-0507.2006.01223.x
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
[show abstract] [hide abstract]
ABSTRACT: This report describes the molecular epidemiology, in vitro susceptibility, colonial and microscopic morphologies, and biochemical features of Trichosporon mycotoxinivorans, a newly recognized pathogen that appears to have a propensity for patients with cystic fibrosis. The index patient died with histologically documented Trichosporon pneumonia complicating cystic fibrosis. This is also the first report of disease caused by a Trichosporon species in a nontransplant patient with cystic fibrosis. As T. mycotoxinivorans has not previously been recognized as a respiratory pathogen, the significance of its recovery from sputum samples was not initially appreciated. Genetic analysis of archived clinical samples found three additional cases of T. mycotoxinivorans infection which had previously been identified as other members of the genus. An additional isolate of T. mycotoxinivorans was identified from a clinical sample on initial testing. Three of these four cases were also patients with cystic fibrosis. All isolates had MICs at 48 h of amphotericin B of > or = 1 microg/ml and of echinocandins of > or = 16 microg/ml, but they displayed various susceptibilities to the triazoles. In summary, Trichosporon mycotoxinivorans is a newly recognized human pathogen that is associated with cystic fibrosis.Journal of clinical microbiology 08/2009; 47(10):3091-7. · 4.16 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
15-year-old boy
5-fluorocytosine
acute lymphoblastic leukaemia
Disseminated infection
emerging mycoses
haematological malignancy
immunosuppressive chemotherapy
Infections
lipid complex amphotericin B
Trichosporon mucoides infection
Trichosporon species